The United States has announced it will cut $50 million in annual aid to Zambia’s health sector, citing the government’s failure to stop “systemic theft” of donated medicines and medical supplies.
U.S. Ambassador to Zambia Michael Gonzales stated that this decision is separate from the broader review of foreign aid being finalized by the Trump administration. He expressed disappointment that since 2021, the U.S. has uncovered the widespread theft of vital medicines, including antiretroviral drugs for HIV treatment, intended for free distribution to the Zambian public.
Zambia’s health ministry acknowledged the U.S. concerns, describing recurrent medicine theft as a “persistent challenge” predating 2021. The ministry said that President Hakainde Hichilema commissioned an independent forensic audit of the entire medicine supply chain after being alerted to the issue.
According to the ministry, several officials found to be involved have been removed from office or suspended, while others have been arrested and are awaiting court appearances. The ministry assured the public that Zambia currently has sufficient stocks of essential medicines, including antiretrovirals, antimalarials, and other critical drugs, and there is no immediate risk of shortages.
Ambassador Gonzales said he has recommended that the U.S. continue to procure and deliver lifesaving medicines and medical supplies to Zambia until January 2026 to allow the government time to develop a transition plan. After January 2026, the U.S. will continue to provide technical and logistics assistance to support humanitarian activities and prevent drug resistance and disease transmission
